Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder

American Journal of Psychiatry

Volumn 162, Issue 1, 2005, Pages 168-174

  Kahl, Kai G ^a,b   Rudolf, Sebastian ^a   Stoeckelhuber, Beate M ^a   Dibbelt, Leif ^a   Gehl, Hans Björn ^a   Markhof, Kerstin ^a   Hohagen, Fritz ^a   Schweiger, Ulrich ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HORMONE; HYDROCORTISONE; IMMUNOLOGIC FACTOR; INTERLEUKIN 2; INTERLEUKIN 6; OSTEOCALCIN; OSTEOPROTEGERIN; SOMATOMEDIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; BORDERLINE STATE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; LUMBAR SPINE; MAJOR DEPRESSION; OSTEOCLAST; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; VOLUNTEER;

ADULT; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BORDERLINE PERSONALITY DISORDER; COLLAGEN; COMORBIDITY; CYTOKINES; DENSITOMETRY, X-RAY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; OSTEOCLASTS; OSTEOPOROSIS; PEPTIDE FRAGMENTS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 11844303446     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.1.168     Document Type: Article

References (31)

1. Van Vort WB, Rubenstein M, Rose RP: Osteoporosis with pathological hip fractures in major depression. J Geriatr Psychiatry Neural 1990; 3:10-12
2. Halbreich U, Palter S: Accelerated osteoporosis in psychiatric patients: possible pathophysiologic processes. Schizophr Bull 1996; 22:447-454
3. Cizza G, Ravn P, Chrousos GP, Gold PW: Depression: a major, unrecognized risk factor for osteoporosis. Trends Endocrinol Metab 2001; 12:198-203
4. Whooley MA, Kip KE, Cauley JA, Ensrud KE, Nevitt MC, Browner WS (Osteoporotic Fractures Research Group): Depression, falls and risk of fracture in older women. Arch Intern Med 1999; 159:484-490
5. Michelson D, Stratakis C, Hill L, Reynolds J, Galliven E, Chrousos G, Gold P: Bone mineral density in women with depression. N Engl J Med 1996; 335:1176-1181
6. Herrán A, Amado JA, García-Unzueta MT, Vázquez- Barquero JL, Perera L, González-Macías J: Increased bone remodelling in first-episode major depressive disorder. Psychosom Med 2000; 62:779-782
7. Heuser I: The hypothalamic-pituitary-adrenal axis in depression. Pharmacopsychiatry 1998; 31:10-13
8. Maes M: Major depression and activation of the inflammatory response syndrome. Adv Exp Med Biol 1999; 461:25-46
9. Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H: Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997; 9:853-858
10. Van West D, Maes M: Activation of the inflammatory response system: a new look at the etiopathogenesis of major depression. Neuro Endocrinol Lett 1999; 20:11-17
11. Frommberger UH, Bauer J, Haselbauer P, Fraulin A, Riemann D, Berger M: Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 1997; 247:228-233
12. Kiecolt-Glaser JK, Glaser R: Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res 2002; 53:873-876
13. Lanqillon S, Krieg J-C, Bening-Abu-Shach U, Vedder H: Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000; 22:370-379
14. Dantzer R, Wollman E, Vitkovic L, Yirmiya R: Cytokines and depression: fortuitous or causative association? Mol Psychiatry 1999; 4:328-332
15. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL: TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000; 106:1481-1488
16. Hofbauer LC, Khosla S, Lacey DL, Dunstan CR, Boyle WJ, Riggs BL: The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000; 15:2-12
17. Corruble E, Ginestet D, Guelfi JD: Comorbidity of personality disorders and unipolar major depression: a review. J Affect Disord 1996; 37:157-170
18. Rossi A, Marinangeli MG, Butti G, Scinto A, Di Cicco L, Kalyvoka A, Petruzzi C: Personality disorders in bipolar and depressive disorders. J Affect Disord 2001; 65:3-8
19. Genant HK: Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 1995; 10:997-998
20. WHO Study Group: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser 1994; 843:1-129
21. Ravn P, Fledelius C, Rosenquist C, Overgaard K, Christiansen C: High bone turnover is associated with low bone mass in both pre- and postmenopausal women. Bone 1996; 19:291-298
22. Peichl P, Griesmacherb A, Marteau R, Hejc S, Kumpan W, Muller MM, Broll H: Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers. Clin Biochem 2001; 34:131-139
23. Hofbauer LC, Neubauer A, Heufelder AE: Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases. Cancer 2001; 92:460-470
24. Orr FW, Lee J, Duivenvoorden WCM, Singh G: Pathophysiologic interactions in skeletal metastasis. Cancer 2000; 88(12 suppl): 2912-2918
25. Guise TA: Molecular mechanisms of osteolytic bone metastases. Cancer 2000; 88(suppl 1):2892-2898
26. Zheng SX, Vrindts Y, Lopez M, De Groote D, Zangerle PF, Collette J, Franchimont N, Geenen V, Albert A, Reginster JY: Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas 1997; 26:63-71
27. Wennberg P, Nordstrom P, Lorentzon R, Lerner UH, Lorentzon M: TNF-alpha gene polymorphism and plasma TNF-alpha levels are related to lumbar spine bone area in healthy female Caucasian adolescents. Eur J Endocrinol 2002; 146:629-634
28. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E: Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003; 170:429-433
29. Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kühn M, Schuld A, Pollmacher T: Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 1999; 33:407-418
30. Hinze-Selch D, Schuld A, Kraus T, Kuhn M, Uhr M, Haack M, Pollmacher T: Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacology 2000; 23:13-19
31. Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK: Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 1999; 15:287-291